Planned adaptive design phase II trial of contusugene ladenovec in patients with colorectal liver metastases.
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2014
At a glance
- Drugs Contusugene ladenovec (Primary) ; Cetuximab; Fluorouracil; Folinic acid; Irinotecan
- Indications Cancer metastases; Colorectal cancer
- Focus Registrational; Therapeutic Use
- 03 Mar 2014 New trial record